GCTK
Price
$6.53
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
8.11M
PEN
Price
$251.06
Change
+$1.32 (+0.53%)
Updated
Jul 3 closing price
Capitalization
8.64B
23 days until earnings call
Interact to see
Advertisement

GCTK vs PEN

Header iconGCTK vs PEN Comparison
Open Charts GCTK vs PENBanner chart's image
GlucoTrack
Price$6.53
Change-$0.00 (-0.00%)
Volume$1.73K
Capitalization8.11M
Penumbra
Price$251.06
Change+$1.32 (+0.53%)
Volume$233.85K
Capitalization8.64B
GCTK vs PEN Comparison Chart in %
Loading...
GCTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GCTK vs. PEN commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCTK is a Buy and PEN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (GCTK: $6.53 vs. PEN: $251.06)
Brand notoriety: GCTK and PEN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GCTK: 0% vs. PEN: 47%
Market capitalization -- GCTK: $8.11M vs. PEN: $8.64B
GCTK [@Medical Specialties] is valued at $8.11M. PEN’s [@Medical Specialties] market capitalization is $8.64B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GCTK’s FA Score shows that 0 FA rating(s) are green whilePEN’s FA Score has 1 green FA rating(s).

  • GCTK’s FA Score: 0 green, 5 red.
  • PEN’s FA Score: 1 green, 4 red.
According to our system of comparison, PEN is a better buy in the long-term than GCTK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GCTK’s TA Score shows that 6 TA indicator(s) are bullish while PEN’s TA Score has 4 bullish TA indicator(s).

  • GCTK’s TA Score: 6 bullish, 3 bearish.
  • PEN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, GCTK is a better buy in the short-term than PEN.

Price Growth

GCTK (@Medical Specialties) experienced а +25.10% price change this week, while PEN (@Medical Specialties) price change was -0.99% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.93%. For the same industry, the average monthly price growth was +1.81%, and the average quarterly price growth was -0.17%.

Reported Earning Dates

GCTK is expected to report earnings on May 14, 2025.

PEN is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Medical Specialties (+1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PEN($8.64B) has a higher market cap than GCTK($8.11M). PEN YTD gains are higher at: 5.718 vs. GCTK (-98.541). PEN has higher annual earnings (EBITDA): 109M vs. GCTK (-5.95M). PEN has more cash in the bank: 289M vs. GCTK (6.89M). GCTK has less debt than PEN: GCTK (184K) vs PEN (234M). PEN has higher revenues than GCTK: PEN (1.06B) vs GCTK (0).
GCTKPENGCTK / PEN
Capitalization8.11M8.64B0%
EBITDA-5.95M109M-5%
Gain YTD-98.5415.718-1,723%
P/E RatioN/A93.70-
Revenue01.06B-
Total Cash6.89M289M2%
Total Debt184K234M0%
FUNDAMENTALS RATINGS
GCTK vs PEN: Fundamental Ratings
GCTK
PEN
OUTLOOK RATING
1..100
4850
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
10069
SMR RATING
1..100
10085
PRICE GROWTH RATING
1..100
9654
P/E GROWTH RATING
1..100
1004
SEASONALITY SCORE
1..100
4950

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GCTK's Valuation (94) in the null industry is in the same range as PEN (96) in the Medical Specialties industry. This means that GCTK’s stock grew similarly to PEN’s over the last 12 months.

PEN's Profit vs Risk Rating (69) in the Medical Specialties industry is in the same range as GCTK (100) in the null industry. This means that PEN’s stock grew similarly to GCTK’s over the last 12 months.

PEN's SMR Rating (85) in the Medical Specialties industry is in the same range as GCTK (100) in the null industry. This means that PEN’s stock grew similarly to GCTK’s over the last 12 months.

PEN's Price Growth Rating (54) in the Medical Specialties industry is somewhat better than the same rating for GCTK (96) in the null industry. This means that PEN’s stock grew somewhat faster than GCTK’s over the last 12 months.

PEN's P/E Growth Rating (4) in the Medical Specialties industry is significantly better than the same rating for GCTK (100) in the null industry. This means that PEN’s stock grew significantly faster than GCTK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GCTKPEN
RSI
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
76%
Momentum
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
76%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 4 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
71%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
GCTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCIAX63.590.61
+0.97%
American Funds Invmt Co of Amer 529-F-2
JDWNX122.650.98
+0.81%
Janus Henderson Global Research N
GSGSX49.020.35
+0.72%
Goldman Sachs Equity Income Svc
HMVSX17.790.08
+0.45%
Hartford MidCap Value R4
CICGX10.93N/A
N/A
AB Concentrated International Growth C

GCTK and

Correlation & Price change

A.I.dvisor tells us that GCTK and QTRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GCTK and QTRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GCTK
1D Price
Change %
GCTK100%
N/A
QTRX - GCTK
32%
Poorly correlated
+0.87%
SIBN - GCTK
30%
Poorly correlated
+0.22%
IMDX - GCTK
24%
Poorly correlated
-6.25%
INMD - GCTK
23%
Poorly correlated
-0.33%
PEN - GCTK
23%
Poorly correlated
+0.53%
More